NZSE:ATM
NZSE:ATMFood

A Look At A2 Milk's (NZSE:ATM) Valuation After Hiring Helena He As Chief Marketing Officer

a2 Milk (NZSE:ATM) has drawn fresh attention after appointing Helena He as Chief Marketing Officer, a move focused on brand, product and execution in China and other key infant nutrition markets. See our latest analysis for a2 Milk. That appointment lands at a time when the shares have eased back, with a 7 day share price return of 8.83% and a 30 day share price return of 5.27%, even though the 1 year total shareholder return is 55% and the 3 year total shareholder return is 35.12%. Recent...
NZSE:AIR
NZSE:AIRAirlines

Does Air New Zealand’s Punctuality And Cabin Upgrades Reset The Bull Case For NZSE:AIR?

Air New Zealand was recently ranked second in the Asia Pacific region for on-time performance in Cirium’s 2025 review, reflecting operational changes such as airport-specific scheduling, enhanced frontline training, and new digital tools to cut delays. At the same time, safety accolades and cabin innovations like Skycouch and the upcoming Skynest are helping Air New Zealand differentiate its service offering while reinforcing its reputation for reliability. We’ll now examine how Air New...
NZSE:WIN
NZSE:WINReal Estate

Asian Penny Stocks With Market Caps Over US$300M To Consider

As Asian markets continue to navigate a landscape of geopolitical tensions and economic shifts, investors are increasingly seeking opportunities in smaller-cap equities. Penny stocks, often representing emerging or less-established companies, offer a unique chance for growth at accessible price points. Despite the term's vintage feel, these stocks can present significant value when backed by strong financials and clear growth potential.
NZSE:IFT
NZSE:IFTDiversified Financial

CDC Valuation Jump Might Change The Case For Investing In Infratil (NZSE:IFT)

In recent days, Infratil reported that the valuation of its CDC data center investment increased by A$349 million over the three months to 31 December 2025, coinciding with broader strength in New Zealand equities. This uplift highlights how Infratil’s focus on data infrastructure can materially influence the value of its portfolio alongside its renewables and essential services exposure. We’ll now examine how the higher CDC valuation shapes Infratil’s investment narrative, particularly...
NZSE:IFT
NZSE:IFTDiversified Financial

Assessing Infratil (NZSE:IFT) Valuation After CDC Uplift And Renewables And Digital Growth Momentum

Infratil (NZSE:IFT) is back in focus after reporting a AU$349 million uplift in the valuation of its CDC data center investment over the past 3 months, alongside supportive commentary around its renewables and digital infrastructure exposure. See our latest analysis for Infratil. At a share price of NZ$11.61, Infratil has a 7 day share price return of 4.78% but a 90 day share price return of a 6.30% decline. Its 5 year total shareholder return of 78.34% points to solid longer term momentum...
NZSE:FBU
NZSE:FBUBuilding

Is Fletcher Building’s Emerging Turnaround Narrative Altering The Investment Case For Fletcher Building (NZSE:FBU)?

Recent commentary has cast Fletcher Building as an underappreciated New Zealand construction and building products group, highlighting its diversified exposure to housing, infrastructure and broader construction cycles after a period of operational challenges. The emerging view that improved execution and a more supportive macro backdrop could mark a turning point is drawing attention to Fletcher Building’s potential as a sleeper play in its local markets. We’ll now examine how this emerging...